IRIS
RIONDINO, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.074
EU - Europa 917
AS - Asia 255
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
AF - Africa 1
Totale 15.263
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.064
UA - Ucraina 175
IE - Irlanda 170
CN - Cina 149
IT - Italia 149
DE - Germania 111
PL - Polonia 105
FR - Francia 78
KR - Corea 70
FI - Finlandia 43
GB - Regno Unito 39
RU - Federazione Russa 11
CA - Canada 10
BE - Belgio 8
IN - India 8
ES - Italia 7
NL - Olanda 6
EU - Europa 5
JP - Giappone 5
SA - Arabia Saudita 5
CH - Svizzera 4
CL - Cile 4
SE - Svezia 4
TR - Turchia 4
BD - Bangladesh 2
BR - Brasile 2
EC - Ecuador 2
HK - Hong Kong 2
LT - Lituania 2
PH - Filippine 2
RO - Romania 2
TW - Taiwan 2
VN - Vietnam 2
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
EG - Egitto 1
ID - Indonesia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TH - Thailandia 1
Totale 15.263
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.134
Wilmington 3.702
Houston 3.576
Fairfield 452
Chandler 297
Ann Arbor 296
Ashburn 220
Seattle 219
Cambridge 204
Dublin 144
Jacksonville 143
Kraków 105
Medford 103
New York 93
Rome 79
Beijing 68
Dearborn 64
San Diego 59
Lawrence 49
Menlo Park 41
Zhengzhou 24
Engelhard 18
Nanjing 10
Detroit 9
Milan 9
Brussels 8
Creede 8
London 7
Norwalk 7
Verona 7
Kunming 6
Falls Church 5
Lappeenranta 5
Monte Vista 5
Mountain View 5
Redwood City 5
Barcelona 4
Boardman 4
Fort Worth 4
Guangzhou 4
Hefei 4
Miami 4
Shanghai 4
Tokyo 4
Toronto 4
Anzio 3
Cedarhurst 3
Chaoyang 3
Hounslow 3
Indiana 3
Los Angeles 3
Nanchang 3
Pataskala 3
Riyadh 3
San Jose 3
Xian 3
Bengaluru 2
Bristol 2
Busto Arsizio 2
Changchun 2
Chengdu 2
Del Norte 2
Dong Ket 2
Edmonton 2
Florence 2
Fremont 2
Hangzhou 2
Helsinki 2
Hong Kong 2
L’Aquila 2
Marino 2
Montreal 2
Mülheim 2
Palo Alto 2
Pune 2
Quito 2
Rostock 2
San Francisco 2
Santa Clara 2
Seoul 2
Taipei 2
Trento 2
Washington 2
Zhongshan 2
Absecon 1
Acton 1
Almaty 1
Amarillo 1
Ariccia 1
Auckland 1
Bangalore 1
Baotou 1
Briosco 1
Caserta 1
Charlotte 1
Chicago 1
Chiswick 1
Cupertino 1
Decimomannu 1
Den Haag 1
Totale 14.327
Salva come PNG Salva come JPEG
Nome #
Sample PREanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols 447
Anti-angiogenic drugs, vascular toxicity and thromboembolism in solid cancer 419
Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients 413
Prognostic value of glycated hemoglobin in colorectal cancer 409
Type 2 diabetes and breast cancer: The interplay between impaired glucose metabolism and oxidant stress 407
Ketogenic diet and other dietary intervention strategies in the treatment of cancer 406
Gender differences in cancer-associated venous thromboembolism 405
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 404
Functional impairment of activated protein C in breast cancer - relationship to survival outcomes 404
Clinical models and biochemical predictors of VTE in lung cancer 403
Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study 402
Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients 401
RISK: A random optimization interactive system based on kernel learning for predicting breast cancer disease progression 400
RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank 397
Biological and predictive role of ERCC1 polymorphisms in cancer 397
Obesity and colorectal cancer: role of adipokines in tumor initiation and progression 395
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 395
Risk assessment for venous thromboembolism in chemotherapy treated ambulatory cancer patients: a machine learning approach 394
VEGF and VTE risk in cancer patients-letter 380
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 378
Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle 375
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression 375
VEGF gene promoter polymorphisms and risk of VTE in chemotherapytreated cancer patients 370
Determinants of homocysteine levels in colorectal and breast cancer patients 369
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 369
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 361
Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy 356
Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study 352
Predictive value of high-density lipoprotein (HDL)-cholesterol for cancer-associated venous thromboembolism during chemotherapy 350
Impact of VEGF gene polymorphisms in elderly cancer patients: Clinical outcome and toxicity 348
Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy 341
Insulin resistance as a predictor of venous thromboembolism in breast cancer 340
Prognostic significance of serum adipokine levels in colorectal cancer patients 336
Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence 334
Breast Cancer Prognosis Using a Machine Learning Approach 310
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 307
Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome 303
SPRECware: software tools for Standard PREanalytical Code (SPREC) labeling - effective exchange and search of stored biospecimens 277
Clinical significance of glycemic parameters on venous thromboembolism risk preDiction in gastrointestinal cancer 260
Precision medicine in the ageing world: The role of biospecimen sciences 258
Predicting VTE in cancer patients: Candidate biomarkers and risk assessment models 195
Irinotecan or oxaliplatin: which is the first move for the mate? 74
Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care 57
Clinical utility of plasma KRAS, NRAS and BRAF mutational analysis with real time PCR in metastatic colorectal cancer patients -The importance of tissue/plasma discordant cases 49
Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review 41
Concordance of blood-based and normal tissue-based dihydropyrimidine dehydrogenase (DPYD) genotyping 33
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 31
Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients 30
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 26
KRAS and BRAF Mutations in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis 25
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 21
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 20
Gender differences in cancer-associated venous thromboembolism 20
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer 17
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling 13
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling 12
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer 11
Biospecimen Digital Twins: Moving from a "High Quality" to a "Fit-for-Purpose" Concept in the Era of Omics Sciences 11
Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis 8
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series 7
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives 7
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) 6
Factor seven activating protease activity levels in women with recurrent pregnancy loss 5
Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities 5
Totale 15.471
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.023
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019942 0 0 0 0 0 0 0 0 0 0 469 473
2019/20204.005 343 313 305 376 374 430 333 341 361 304 243 282
2020/20212.348 245 282 223 286 289 251 323 222 51 58 92 26
2021/2022652 28 50 11 10 19 30 69 109 38 130 33 125
2022/2023736 73 66 11 86 97 163 48 68 58 12 29 25
2023/2024285 35 10 23 23 28 96 42 12 9 7 0 0
Totale 15.471